Results 31 to 40 of about 2,921 (250)

Patients' attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study [PDF]

open access: yes, 2017
Background Suboptimal thyroid hormone replacement is common in patients with hypothyroidism and the behavioural factors underlying this are poorly understood.
Dayan, Colin   +10 more
core   +2 more sources

Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis [PDF]

open access: yes, 2015
Background: As far as we are aware, no previous systematic review and synthesis of the qualitative/descriptive literature on polypharmacy in anabolic-androgenic steroid(s) (AAS) users has been published. Method: We systematically reviewed and synthesized
AJ Gruber   +74 more
core   +2 more sources

Successful Oral Levothyroxine Desensitization in a Patient with Severe Hypothyroidism Post Radioactive Iodine Therapy

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2022
Levothyroxine remains the standard therapy for patients with hypothyroidism worldwide. Levothyroxine allergy is rarely seen and alternative therapies are less efficacious and scarcely available. The use of liothyronine (LT3) monotherapy is less favoured
Yi Jiang Chua   +4 more
doaj   +1 more source

Fatigue and TSH Levels in Hypothyroid Patients [PDF]

open access: yes, 2012
Background. Fatigue is often the complaint that initiates thyroid function investigation. Most available data related to fatigue and hypothyroidism involved patients with subclinical hypothyroidism where fatigue was not the primary outcome.
El Bizri, Issam   +4 more
core   +2 more sources

Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form

open access: yesJournal of Applied Pharmaceutical Research
Background: Levothyroxine and Liothyronine are widely used in thyroid hormone replacement therapies. Simultaneously quantifying Levothyroxine and Liothyronine is important for managing thyroid hormone deficiency.
Ramdas Darade, Sanjay Pekamwar
doaj   +1 more source

Sustained Release T3 Therapy: Animal Models and Translational Applications

open access: yesFrontiers in Endocrinology, 2019
The standard of care to treat hypothyroidism is daily administration of levo-thyroxine (LT4). This is based on the understanding that deiodinases can restore production of T3 and compensate for the small amounts of T3 that are normally produced by the ...
Thaer Idrees   +4 more
doaj   +1 more source

Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function

open access: yesFrontiers in Endocrinology, 2019
Objective: To gain insight into the mixed results of reported combination therapy studies conducted with levothyroxine (LT4) and liothyronine (LT3) between 1999 and 2016.Methods: We defined trial success as improved clinical outcome measures and/or ...
Joseph DiStefano, Jacqueline Jonklaas
doaj   +1 more source

Dental management of patients with endocrine disorders [PDF]

open access: yes, 2010
Introduction: The endocrine system is responsible for hormonal secretion and is closely related to the central nervous system, as it diversifies its functions through the hypothalamus and pituitary glands.
Carlos Fabuel, Laura   +2 more
core   +1 more source

Successful treatment of myxedema coma using levothyroxine and liothyronine in the setting of adrenal crisis and severe cardiogenic shock in a patient with apparent primary empty sella

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2021
Hypothyroidism is a common pathological condition of thyroid hormone deficiency that varies widely in relation to both the acuity with which the deficiency develops and the clinical manifestations of the disease.
Omar Elghawy   +3 more
doaj   +1 more source

Thyroid-hormone therapy and thyroid cancer: a reassessment. [PDF]

open access: yes, 2005
Experimental studies and clinical data have demonstrated that thyroid-cell proliferation is dependent on thyroid-stimulating hormone (TSH), thereby providing the rationale for TSH suppression as a treatment for differentiated thyroid cancer.
BIONDI, BERNADETTE   +2 more
core  

Home - About - Disclaimer - Privacy